XML 41 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
3 Months Ended
Jul. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Activity
A summary of the Company’s option activity during the three months ended July 31, 2021 is as follows:
Options Outstanding
Number of
Stock Options
Outstanding
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (years)
Aggregate
Intrinsic
Value
(in thousands)(in thousands)
Balance as of April 30, 202138,487 $6.39 7.98$2,304,714 
Options granted2,159 59.28 
Options exercised(1,693)2.99 
Options cancelled(331)10.81 
Balance as of July 31, 202138,622 $9.46 7.90$1,579,329 
Vested and exercisable as of July 31, 202113,634 $3.71 6.75$635,917 
Vested and expected to vest as of July 31, 2021(1)
39,460 $9.36 7.90$1,617,305 
(1) The number of options vested and expected to vest as of July 31, 2021 includes early exercised, unvested Class A common stock. Refer to Note 8. Stockholders’ Equity for more information.
Schedule of Valuation Assumptions The weighted average assumptions underlying the fair value estimation are provided in the following table:
Three Months Ended July 31,
20212020
Valuation assumptions:
Expected dividend yield— %— %
Expected volatility44.5 %42.6 %
Expected term (years)6.36.2
Risk-free interest rate0.8 %0.4 %
Schedule of Restricted Stock Unit Activity
A summary of the Company’s RSU activity during the three months ended July 31, 2021 is as follows:
RSUs Outstanding
Number of RSUsWeighted Average
Grant Date Fair Value
Per Share
(in thousands)
Unvested Balance as of April 30, 2021447 $74.52 
RSUs granted3,537 60.69 
RSUs vested(8)74.52 
RSUs forfeited(78)66.98 
Unvested Balance as of July 31, 20213,898 $62.12 
Summary of Effects of Stock-Based Compensation
The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands):
Three Months Ended July 31,
20212020
Cost of subscription$821 $184 
Cost of professional services602 48 
Sales and marketing6,135 855 
Research and development2,758 458 
General and administrative3,596 935 
Total stock-based compensation expense$13,912 $2,480